Dolutegravir Safety Review: WHO Subcommittee Meeting

Name: Dolutegravir Safety Review: WHO Subcommittee Meeting
Start: 2019-05-06T09:00:00+02:00
End: 2019-05-06T18:00:00+02:00
Location: WHO Building

Monday 6 May 2019, 09:00 → 18:00 Europe/Zurich

In-Person

E170 (WHO Building, Geneva, Switzerland)

E170

WHO Building

Avenue Appia 20, 1202, Geneva, Switzerland

Description

Meeting of the sub-committee of the WHO Advisory Committee on Safety of Medicinal Products (ACSoMP) on the signal of neural tube defect (NTD) with dolutegravir

Eirini Neofytou

neofytoue@who.int

+41227911832

The agenda of this meeting is empty